- Customer Help
- +91 8432334499
Pashanbhed Churna (50GM)
₹30.00
| Pashanbhed is mostly used for the removal of kidney and urinary tract stones due to its antilithic property. According to Ayurveda, consuming Pashanbhed powder increases urine production and helps in the easy removal of stones due to its Mutral (diuretic) property. Pashanbhed might also help in reducing fever due to its antipyretic property and give relief from cough due to its antitussive properties. It might also help manage ulcers due to its antioxidant and antiulcer properties. You can apply Pashanbhed paste on the skin to manage boils and inflammation due to its anti-inflammatory property. Pashanbhed Powder – 1-3 gm twice a day or as directed by a physician. |
Share This Items :
Pan India Delivery
Fast & Reliable
COD Available
Cash on delivery!
Safety chekout
For every purchased
⚠️ Health Disclaimer
The information provided in this app is for general wellness and educational purposes only. It does not substitute professional medical advice, diagnosis, or treatment. Always consult your doctor or qualified healthcare provider before starting any new health program or treatment.
| Pashanbhed is mostly used for the removal of kidney and urinary tract stones due to its antilithic property. According to Ayurveda, consuming Pashanbhed powder increases urine production and helps in the easy removal of stones due to its Mutral (diuretic) property. Pashanbhed might also help in reducing fever due to its antipyretic property and give relief from cough due to its antitussive properties. It might also help manage ulcers due to its antioxidant and antiulcer properties. You can apply Pashanbhed paste on the skin to manage boils and inflammation due to its anti-inflammatory property. Pashanbhed Powder – 1-3 gm twice a day or as directed by a physician. |
Only logged in customers who have purchased this product may leave a review.
Related products
Safed Musli Churna (50GM)
₹504.00
Behada Churna (50GM)
₹33.00
Amla Churna (100GM)
₹153.00
Reviews
There are no reviews yet.